How is Thymalin administered?
This describes how Thymalin is typically administered in clinical and research references, not a self-administration guide. The usual route is Intramuscular (clinical) or subcutaneous (research use), on a daily for 10 days, then off schedule, generally over 10-day course, repeated 2-3x per year. Specific dosing is individual and beyond general information, and human evidence for Thymalin is limited.
Administration at a glance (reference data)
- Route: Intramuscular (clinical) or subcutaneous (research use)
- Schedule: Daily for 10 days, then off
- Cycle length: 10-day course, repeated 2-3x per year
- Half-life: Short, minutes in plasma; biological effect persists days
References
- Peptides of pineal gland and thymus prolong human life — Khavinson VKh, Morozov VG, Neuro Endocrinol Lett, 2003
- The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19 — Linkova N, et al., Int J Mol Sci, 2023
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Thymalin
Last updated 2026-06-15.